FilingReader Intelligence
Zydus gets first Health Canada approval for smoking cessation tablets
August 7, 2025 at 07:14 PM UTC•By FilingReader AI
Zydus Lifesciences announced it received Health Canada approval for its varenicline tablets (0.5mg & 1mg) for smoking cessation, marking the company's first Notice of Compliance in Canada.
Varenicline tablets recorded annual sales of CAD 15 million in Canada as of December 2024.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:ZYDUSLIFE•Bombay Stock Exchange
News Alerts
Get instant email alerts when Zydus Lifesciences publishes news
Free account required • Unsubscribe anytime